|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants显示文摘AIM: To evaluate survival data in patients with gastric cancer in relation to postoperative adjuvant therapy and survival determinantsMETHODS: A total of 201 patients(mean ± SD age: 56.0 ± 11.9 years, 69.7% were males) with gastric carcinoma who were operated and followed up at Lutfi Kirdar Kartal Training and Research Hospital between 1998 and 2010 were included in this retrospective study. Follow up was evaluated divided into two consecutive periods(before 2008 and 2008-2010, respectively) based on introduction of 3-D conformal technique in radiotherapy at our clinic in 2008. Data on patient demographics, clinical and histopathological characteristics of gastric carcinoma and the type of treatment applied after surgery [postoperative adjuvant treatment protocols including chemoradiotherapy(CRT) and chemotherapy(CT), supportive therapy or follow up without any treatment] were recorded. The median duration and determinants of local recurrence free(LRF) survival, distant metastasis free(DMF) survival and overall survival were evaluated in the overall population as well as with respect to follow up years [1998-2008(n = 127) vs 2008-2010(n = 74)].RESULTS: Median duration for LRF survival, DMF survival and overall survival were 31.9, 24.1 and 31.9 mo, respectively in patients with postoperative adjuvant CRT. No significant difference was noted in median duration for LRF survival, DMF survival and overall survival with respect to treatment protocols in the overall population and also with respect to followed up periods. In the overall population, CT protocols FUFA [5-fluorouracil(400 mg/m2) and leucovorin-folinic acid(FA, 20 mg/m2)](29.9 mo) and UFT + Antre [a fixed combination of the oral FU prodrug tegafur(flouroprymidine, FT, 300 mg/m2 per day) with FA(Antrex?), 15 mg tablet, two times a day](42.5 mo) was significantly associated with longer LRF survival times than other CT protocols(P = 0.036), while no difference was noted between CT protocols in terms of DMF survival and overall survival. Among patients received CRT, overall survival was significantly longer in patients with negative than positive surgical margin(27.7 mo vs 22.4 mo, P = 0.016) in the overallstudy population, while time of radiotherapy initiation had no significant impact on survival times. Nodal stage was determined to be independent predictor of LRF survival in the overall study population with 4.959 fold(P = 0.042) increase in mortality in patients with nodal stage N2 compared to patients with nodal stage N0, and independent predictor of overall survival with 5.132 fold(P = 0.006), 5.263 fold(P = 0.027) and 4.056 fold(P = 0.009) increase in the mortality in patients with nodal stage N3a(before 2008), N3b(before 2008) and N2(overall study population) when compared to patients with N0 stage, respectively.CONCLUSION: Our findings emphasize the likelihood of postoperative adjuvant CRT to have a survival benefit in patients with resectable gastric carcinoma. | Sevgi Ozden Zerrin Ozgen Hazan Ozyurt Cengiz Gemici Gokhan Yaprak Huseyin Tepetam Alpaslan Mayadagli | 2015 | World Journal of Gastroenterology2015，21，4： | 7 |
| 2 | Prognostic significance of thrombocytosis in node-negative colon cancer显示文摘 | Kandemir EG Mayadagli A Karagoz B | | 0，，02： | 1 |
| 3 | Outcome of metastatic non- small cell lung carcinoma patients receiving docetaxel and cisplatin combination chemotherapy : single institution experience 显示文摘 | Kocak M Mayadagli A Ozkan A | 2007 | J BUON2007，12，4： | 1 |
| 4 | Risk of endocrine pancreatic insufficiency in patients receiving adjuvant chemoradiation for resected gastric cancer显示文摘 | Cengiz Gemici Mehmet Sargin Oya Uygur-Bayramicli Alpaslan Mayadagli Gokhan Yaprak Resat Dabak Mihriban Kocak | 2013 | Radiotherapy and Oncology2013，，2： | 1 |
| 5 | Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer:a single institution review of two different regimens显示文摘 | Kocak M Ozkan A Mayadagli A | 2009 | C lin Lung Cancer2009，10，： | 1 |
| 6 | Cases of extranodal lymphoma inthe head and neck region显示文摘 | Bilge S Mayadagli A Ozseker N | 2007 | ASCO Annual Meeting Proceedings2007，25，18： | 1 |
| 7 | Outcome of metastatic non- small cell lung carcinoma patients receiving docetaxel cisplatin combination chemotherapy: single institution experience 显示文摘 | Kocak M Mayadagli A Ozkan A | 2007 | J BUON2007，12，4： | 1 |
| 8 | Prognostic significance of thrombocytosis in node-negative colon cancer显示文摘 | Kandemir EG Mayadagli A Karagoz B | 2005 | J Int Med Res2005，33，2： | 1 |
| 9 | Pre-treamient haemoglobin concentration is a prognostic factor in patients with early-stage breast cancer 显示文摘 | Kandemir EG Mayadagli A Turken O | 2005 | J Int Med Res2005，33，： | 1 |
| 10 | Prognostic significance of thrombocytos s in node-negative colon cancer显示文摘 | Kandemir ED Mayadagli A Karagoz B | 2005 | J Int Med Res2005，33，2： | 1 |
| 11 | Elective bladder preservation with muhimodality treatment for bladder cancer 显示文摘 | Mayadagli A Kocak M Demir O | 2012 | J BUON2012，17，3： | 1 |
| 12 | Outcome of metastatic nonsmall cell lung carcinoma patients receiving docetaxel cisplatin combination chemotherapy: single institution experience 显示文摘 | Kocak M Mayadagli A Ozkan A | 2007 | J BUON2007，12，4： | 1 |
| 13 | Cases of extranodal lymphoma in the head and neck region显示文摘 | Bilge S Mayadagli A Ozseker C | | 0，，28： | 1 |
| 14 | , Elective bladder preservation with multimodality treatment for bladder cancer 显示文摘 | MAYADAGLI A KOCAK M DEMIR O | 2012 | JBUON2012，17，3： | 1 |
| 15 | Radiation induced carotid vessel injury in patients with nasopharyngeal cancer显示文摘 | Mayadagli A Gemici C Yaprak G | 2008 | ASCO Meeting Abstracts2008，26，17： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员